Stephen Gough is the Senior Vice President and Global Chief Medical Officer at Novo Nordisk A/S. He initially joined the company in 2015 as Senior Principal Clinical Scientist in the Chief Medical Office, offering expertise in the development of diabetes and obesity treatments. Over the years, his role evolved, and in 2018, he assumed the position of Senior Vice President and Global Chief Medical Officer. Prior to his tenure at Novo Nordisk, Stephen held leadership positions at the Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM) in the UK, where he also served as a Professor of Diabetes at the University of Oxford. His extensive research portfolio covers areas such as autoimmune disease genetics, glucose homeostasis, pancreas transplantation, and clinical trials of GLP-1 therapies. Since joining Novo Nordisk, he continues to contribute his medical expertise in the realms of diabetes, obesity, and biopharmaceuticals.